• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性素 A 与围产期心肌病患者产后血压的相关性。

Association of activin A and postpartum blood pressure in peripartum cardiomyopathy.

机构信息

University of Pittsburgh Medical Center, Pittsburgh, PA, United States.

University of Pittsburgh Medical Center, Pittsburgh, PA, United States.

出版信息

Pregnancy Hypertens. 2023 Dec;34:60-66. doi: 10.1016/j.preghy.2023.10.002. Epub 2023 Oct 16.

DOI:10.1016/j.preghy.2023.10.002
PMID:37852074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10841355/
Abstract

BACKGROUND

Activin A has been implicated in the pathogenesis of patients with chronic hypertension and heart failure as well as patients with hypertensive disorders of pregnancy (HDP). Whether activin A correlates with blood pressure in patients with peripartum cardiomyopathy (PPCM) and HDP history has not previously been explored.

METHODS AND RESULTS

82 women with PPCM w/ and w/out HDP or hypertension history were selected for analysis from the Investigations in Pregnancy Associated Cardiomyopathy (IPAC) study. Serum biomarkers and blood pressure were assessed at the time of enrollment (median postpartum day 24). Levels of both sFlt-1 (SBP: r 0.47, p = 0.008; DBP: r 0.57, p < 0.001) and activin A (SBP: r 0.59, p < 0.001;DBP: r 0.68, p < 0.001) were noted to significantly correlate with blood pressure in patients with a history of HDP who went on to develop PPCM, but not in patients with chronic hypertension or no hypertensive history. The strongest correlation was between activin A levels and postpartum diastolic blood pressure for the subset with preeclampsia (DBP: r0.82, p < 0.001). This remained significant in multivariable linear regression analysis (DBP: β = 0.011, p = 0.015).

CONCLUSION

In patients with PPCM, activin A and sFlt-1 levels had direct correlations with both systolic (SBP) and diastolic blood pressures (DBP), but only in participants with history of HDP. This correlation was more evident for activin A and strongest with a history of preeclampsia. Our findings suggest that activin A may play an important role in blood pressure modulation in women with HDP who subsequently develop PPCM.

摘要

背景

激活素 A 与慢性高血压和心力衰竭患者以及妊娠高血压疾病(HDP)患者的发病机制有关。在患有围产期心肌病(PPCM)和 HDP 病史的患者中,激活素 A 是否与血压相关,目前尚未探讨。

方法和结果

从妊娠相关心肌病研究(IPAC)中选择了 82 名患有 PPCM 伴或不伴 HDP 或高血压病史的女性进行分析。在入组时(产后第 24 天中位数)评估血清生物标志物和血压。既往有 HDP 病史的患者发生 PPCM 后,sFlt-1(SBP:r0.47,p=0.008;DBP:r0.57,p<0.001)和激活素 A(SBP:r0.59,p<0.001;DBP:r0.68,p<0.001)的水平均与血压显著相关,但在患有慢性高血压或无高血压病史的患者中则不然。在子痫前期亚组中,激活素 A 水平与产后舒张压之间的相关性最强(DBP:r0.82,p<0.001)。多元线性回归分析结果仍有统计学意义(DBP:β=0.011,p=0.015)。

结论

在患有 PPCM 的患者中,激活素 A 和 sFlt-1 水平与收缩压(SBP)和舒张压(DBP)均有直接相关性,但仅在有 HDP 病史的患者中存在。对于激活素 A 而言,这种相关性更为明显,与子痫前期病史的相关性最强。我们的研究结果表明,激活素 A 在随后发生 PPCM 的患有 HDP 的女性中可能在血压调节中发挥重要作用。

相似文献

1
Association of activin A and postpartum blood pressure in peripartum cardiomyopathy.活性素 A 与围产期心肌病患者产后血压的相关性。
Pregnancy Hypertens. 2023 Dec;34:60-66. doi: 10.1016/j.preghy.2023.10.002. Epub 2023 Oct 16.
2
Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort study.妊娠高血压疾病与围生期心肌病:一项全国性队列研究。
PLoS One. 2019 Feb 20;14(2):e0211857. doi: 10.1371/journal.pone.0211857. eCollection 2019.
3
Importance of Early Diagnosis in Peripartum Cardiomyopathy.围生期心肌病早期诊断的重要性。
Hypertension. 2020 Jan;75(1):91-97. doi: 10.1161/HYPERTENSIONAHA.119.13291. Epub 2019 Nov 11.
4
Peripartum Cardiomyopathy and Preeclampsia: Overlapping Diseases of Pregnancy.围产期心肌病和子痫前期:妊娠重叠性疾病。
Curr Hypertens Rep. 2018 Jul 3;20(8):69. doi: 10.1007/s11906-018-0868-9.
5
The Association between Hypertensive Disorders of Pregnancy and Peripartum Cardiomyopathy.妊娠期高血压疾病与围产期心肌病之间的关联。
Cureus. 2019 Oct 8;11(10):e5867. doi: 10.7759/cureus.5867.
6
Epidemiology and outcomes of peripartum cardiomyopathy in the United States: findings from the Nationwide Inpatient Sample.美国围产期心肌病的流行病学及预后:来自全国住院患者样本的研究结果
J Cardiovasc Med (Hagerstown). 2016 Oct;17(10):756-61. doi: 10.2459/JCM.0000000000000222.
7
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy.种族、妊娠高血压疾病与围生期心肌病的结局。
Am Heart J. 2024 Oct;276:60-69. doi: 10.1016/j.ahj.2024.07.002. Epub 2024 Jul 10.
8
Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study.围生期心肌病患者外周血 T 细胞亚群、单核细胞和自然杀伤细胞:多中心 IPAC 研究结果。
J Card Fail. 2018 Jan;24(1):33-42. doi: 10.1016/j.cardfail.2017.10.012. Epub 2017 Oct 24.
9
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human.胎盘衰老的病理生理学在小鼠和人类的围产期心肌病和子痫前期中是共有的。
Sci Transl Med. 2024 Apr 17;16(743):eadi0077. doi: 10.1126/scitranslmed.adi0077.
10
Peripartum Screening for Postpartum Hypertension in Women With Hypertensive Disorders of Pregnancy.对患有妊娠高血压疾病的女性进行产后高血压的围产期筛查。
J Am Coll Cardiol. 2022 Oct 11;80(15):1465-1476. doi: 10.1016/j.jacc.2022.07.028.

引用本文的文献

1
Peripartum Cardiomyopathy: A Case Report of Mortality From a Rare and Potentially Fatal Condition.围产期心肌病:一例罕见且可能致命疾病导致死亡的病例报告。
J Med Cases. 2024 Aug;15(8):171-179. doi: 10.14740/jmc4228. Epub 2024 Jul 18.

本文引用的文献

1
Long-Term Postpartum Cardiac Function and Its Association With Preeclampsia.长期产后心脏功能及其与子痫前期的关系。
J Am Heart Assoc. 2021 Feb;10(5):e018526. doi: 10.1161/JAHA.120.018526. Epub 2021 Feb 23.
2
Biomarkers and Their Relation to Cardiac Function Late After Peripartum Cardiomyopathy.围生期心肌病后晚期的生物标志物及其与心功能的关系。
J Card Fail. 2021 Feb;27(2):168-175. doi: 10.1016/j.cardfail.2021.01.002. Epub 2021 Jan 8.
3
Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia: A Systematic Review and Meta-analysis.生物标志物与子痫前期不良结局的预测:系统评价和荟萃分析。
Obstet Gynecol. 2021 Jan 1;137(1):72-81. doi: 10.1097/AOG.0000000000004149.
4
Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women.产前阿司匹林治疗可降低子痫前期女性的激活素 A 和心脏整体纵向应变。
J Am Heart Assoc. 2020 Jun 16;9(12):e015997. doi: 10.1161/JAHA.119.015997. Epub 2020 Jun 4.
5
Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.联合生物标志物预测妊娠并发症并重新定义子痫前期:血管生成-胎盘综合征
Hypertension. 2020 Apr;75(4):918-926. doi: 10.1161/HYPERTENSIONAHA.119.13763. Epub 2020 Feb 17.
6
Activin type II receptor signaling in cardiac aging and heart failure.激活素 II 型受体信号在心脏衰老和心力衰竭中的作用。
Sci Transl Med. 2019 Mar 6;11(482). doi: 10.1126/scitranslmed.aau8680.
7
Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients.将血管生成因子估测作为提示先兆子痫相关围产期发病率的指标:一项对住院患者的研究。
Hypertension. 2019 Apr;73(4):868-877. doi: 10.1161/HYPERTENSIONAHA.118.12205.
8
Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy.活性素 A 与妊娠高血压疾病女性的产后晚期心脏功能障碍。
Hypertension. 2018 Jul;72(1):188-193. doi: 10.1161/HYPERTENSIONAHA.118.10888. Epub 2018 May 29.
9
Impact of Preeclampsia on Clinical and Functional Outcomes in Women With Peripartum Cardiomyopathy.子痫前期对围产期心肌病女性临床及功能结局的影响。
Circ Heart Fail. 2017 Jun;10(6). doi: 10.1161/CIRCHEARTFAILURE.116.003797.
10
Maternal circulating levels of transforming growth factor-β superfamily and its soluble receptors in hypertensive disorders of pregnancy.妊娠高血压疾病中母体循环中转化生长因子-β超家族及其可溶性受体的水平
Int J Gynaecol Obstet. 2017 Jun;137(3):246-252. doi: 10.1002/ijgo.12142. Epub 2017 Mar 31.